Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
Get Alerts MRVI Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter financial and operating results after the market close on Wednesday, November 4, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial 1-800-343-4849 or 1-203-518-9848 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261014499369/en/
Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
[email protected]
Source: Maravai LifeSciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicharm Announces Full-Scale Operation of East African Subsidiary "SOFY UNICHARM EAST AFRICA," Unveiling Direct Sales Strategy and 2030 Goals
- Mercuryo Launches Swaps for Seamless Movement Between Digital Tokens
- TFP Fertility Group Expands UK Presence with Acquisition of Manchester Fertility Group
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share